Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Resmed Inc. buy Morgan Stanley

Start price
€203.60
19.03.25 / 50%
Target price
-
19.03.26
Performance (%)
5.84%
Price
€215.50
03.12.25
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley shows slight gains of 5.84%. This prediction currently runs until 19.03.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Resmed Inc. -2.045% -2.045%
iShares Core DAX® 0.142% -1.511%
iShares Nasdaq 100 0.833% -2.600%
iShares Nikkei 225® -0.829% -7.040%
iShares S&P 500 0.008% -1.196%

Comments by Morgan_Stanley for this prediction

In the thread Resmed Inc. diskutieren

ResMed Inc. (NYSE: RMD) is now covered by analysts at Morgan Stanley. They set an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat

Stopped prediction by Morgan_Stanley for Resmed Inc.

buy
Resmed Inc.

Start price
Target price
Perf. (%)
€230.40
21.10.25
€261.08
21.10.26
-6.47%
03.12.25

buy
Resmed Inc.

Start price
Target price
Perf. (%)
€126.35
27.10.23
€160.06
27.10.24
89.47%
28.10.24